From the ∗Department of Diagnostic and Interventional Radiology, University Medical Center Goettingen, Goettingen, Germany
†Department of Radiology, University College London Hospital NHS Foundation Trust
‡Division of Surgery and Interventional Science, University College London, London, United Kingdom
§Biomedical NMR, Max Planck Institute for Multidisciplinary Sciences
∥German Center for Cardiovascular Research DZHK, partner site Goettingen
¶Department of Urology, University Medical Center Goettingen, Goettingen, Germany.
Received for publication September 1, 2022; and accepted for publication, after revision, November 1, 2022.
Conflicts of interest and sources of funding: Francesco Giganti is a recipient of the 2020 Young Investigator Award (20YOUN15) funded by the Prostate Cancer Foundation/CRIS Cancer Foundation. Francesco Giganti reports consulting fees from Lucida Medical LTD outside of the submitted work. The authors have no further conflict of interest.
Correspondence to: Johannes Uhlig, MD, MPH, Department of Diagnostic and Interventional Radiology, University Medical Center Goettingen, Robert-Koch-Strasse 40, 37075 Goettingen, Germany. E-mail: [email protected].
Supplemental digital contents are available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s Web site (www.investigativeradiology.com).